Managing IP is part of the Delinian Group, Delinian Limited, 8 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 00954730
Copyright © Delinian Limited and its affiliated companies 2023

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Germany: Determining litigation value in patent appeals

At last, Germany has clear guidelines regarding the litigation value of an appeal to the German Federal High Court of Justice (BGH) in patent application or opposition matters.

In its recent decision X ZB 3/15-Ratschenschlüssel II, the BGH provides patent applicants, patentees and opponents with clear guidelines on lower limits for the litigation value of an appeal to the BGH. Such appeals are possible under the German Patent Act subsequent to first instance appeal proceedings before the Federal Patent Court regarding a patent application or an opposition.

The determination of the litigation value of appeal proceedings before the Federal Court of Justice has to follow the same rules applicable to appeal proceedings before the Federal Patent Court. The litigation value shall therefore be determined with fair discretion, taking into account the parties' interest, but is limited by the value of the underlying judicial procedure.

In the case of an opposition to a patent, the objective interest of the parties may be quantifiable based on the value of the patent plus any claims for damages for which, in the absence of any other indication, the litigation value of pending or past infringement proceedings may provide the most tangible indication. The value of a patent that goes beyond this can be calculated with a surcharge of one quarter of the value of the infringement proceedings.

If there is no sufficient factual evidence for such an estimation, as in proceedings regarding a patent application, or in opposition proceedings without infringement of the patent, the value has to be determined differently. The fact that an applicant invests effort and expenses in the filing of a patent application and appealing against its refusal, and that the applicant will usually do so only in expectation of an associated economic benefit, justifies a minimum litigation value of €50,000 ($57,000). If a patent is opposed, a higher value is justified, namely €75,000 in case of a single opponent. If several parties oppose, this usually reflects an even greater general interest in the revocation of the patent, which justifies a further increase by €25,000 for each additional opponent.

Headnote BGH X ZB 3/15 (translated): The litigation value of the subject matter of a patent lawsuit shall be determined based on the reasonable interest of the appellant in accordance with the principles governing the valuation in nullity proceedings, if there is sufficient factual evidence for an estimate of the patent's intrinsic value. Otherwise, the litigation value in application proceedings is regularly €50,000. In opposition proceedings, the higher general interest is usually to be taken into account by means of a surcharge of €25,000 per opponent.


Stefanie Parchmann

Maiwald Patentanwalts GmbHElisenhof, Elisenstr 3D-80335, Munich, GermanyTel: +49 89 74 72 660 Fax: +49 89 77 64

more from across site and ros bottom lb

More from across our site

Brands should not be deterred from pursuing lookalike producers, and an unfair advantage claim could be the key, say Emma Teichmann and Geoff Steward at Stobbs
Justice Mellor’s highly anticipated ruling surprised SEP owners and reassured implementers that the UK may not be so hostile after all
The England and Wales High Court's judgment comes ahead of a separate hearing concerning one of the patents-in-suit at the EPO
While the rules allow foreign firms to open local offices and offer IP services, a ban on litigation and practising Indian law could mean little will change
A New York federal court heard oral arguments this week in a copyright case pitting publishing giants against a digital library
Commissioner Hamano Koichi shares his vision for the JPO and explains that IP offices must promote innovation that drives social change
The Asia-Pacific awards research cycle has now begun – don’t miss on this opportunity be recognised in 2023
The Supreme Court, which is hearing two IP cases this week, should limit the power of US courts to rule on foreign sales
Safety standards wouldn’t lose copyright protection when named in law, so long as they were accessible for free online
In-house tech sources say Amgen v Sanofi has the potential to stifle their prosecution and litigation strategies if SCOTUS’s decision is too broad